Table 2.
Comp. | R1 | R2 | PET inhibition IC50 [μmol/L] | log P ACD/Log P | σ [35] |
---|---|---|---|---|---|
20 | i-Pr | H | 353 | 2.97 ± 0.28 | −0.19 [36] |
21 | –C12H25 | H | 845 | 7.94 ± 0.28 | NF |
22 | –(CH2)4– | ND | 2.10 ± 0.23 | NF | |
23 | –(CH2)5– | ND | 2.67 ± 0.23 | NF | |
24 | c-Pn | H | ND | 3.59 ± 0.28 | −0.20 [36] |
25 | c-Hx | H | ND | 4.15 ± 0.28 | −0.15 [36] |
26 | c-Hp | H | 216 | 4.21 ± 0.28 | NF |
27 | c-Oc | H | 688 | 5.28 ± 0.28 | NF |
28 | Ph | H | 20.7 | 3.85 ± 0.29 | 0.60 [36]/0 |
29 | Bn | H | 7.5 | 3.87 ± 0.28 | 0.22 [36] |
30 | –C2H4Ph | H | ND | 4.28 ± 0.29 | 0.08 [36] |
31b | 3-OH-Ph | H | ND | 3.50 ± 0.31 | 0.12 |
31c | 4-OH-Ph | H | ND | 3.11 ± 0.30 | −0.37 |
32a | 2-OCH3-Ph | H | 763.0 | 3.75 ± 0.32 | −0.39 [37] |
32b | 3-OCH3-Ph | H | 306.2 | 4.01 ± 0.32 | 0.12 |
32c | 4-OCH3-Ph | H | ND | 3.80 ± 0.32 | −0.27 |
33a | 2-CH3-Ph | H | ND | 4.31 ± 0.30 | NF |
33b | 3-CH3-Ph | H | ND | 4.31 ± 0.30 | −0.07 |
33c | 4-CH3-Ph | H | ND | 4.31 ± 0.30 | −0.17 |
34a | 2-F-Ph | H | ND | 3.82 ± 0.40 | 0.24 [38] |
34b | 3-F-Ph | H | ND | 4.34 ± 0.41 | 0.34 |
34c | 4-F-Ph | H | ND | 4.30 ± 0.41 | 0.06 |
35a | 2-Cl-Ph | H | ND | 4.36 ± 0.32 | 0.20 [38] |
35b | 3-Cl-Ph | H | 81.0 | 4.88 ± 0.33 | 0.37 |
35c | 4-Cl-Ph | H | ND | 4.84 ± 0.32 | 0.23 |
36a | 2-Br-Ph | H | ND | 4.54 ± 0.40 | 0.21 [38] |
36b | 3-Br-Ph | H | 102.8 | 5.06 ± 0.41 | 0.39 |
36c | 4-Br-Ph | H | ND | 5.02 ± 0.41 | 0.23 |
37b | 3-CF3-Ph | H | 309.4 | 5.20 ± 0.39 | 0.43 |
37c | 4-CF3-Ph | H | ND | 4.86 ± 0.37 | 0.74 |
38a | 2-NO2-Ph | H | ND | 4.10 ± 0.34 | 0.80 [38] |
38b | 3-NO2-Ph | H | 633.3 | 4.24 ± 0.34 | 0.71 |
38c | 4-NO2-Ph | H | 260.0 | 4.31 ± 0.34 | 1.26 |
DCMU | – | – | 1.9 | – | – |